BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29726962)

  • 1. Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer.
    Barneh F; Mirzaie M; Nickchi P; Tan TZ; Thiery JP; Piran M; Salimi M; Goshadrou F; Aref AR; Jafari M
    Brief Bioinform; 2019 Mar; 20(2):717-731. PubMed ID: 29726962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.
    Jung SH; Kim SM; Lee CE
    Oncotarget; 2016 Sep; 7(38):62559-62571. PubMed ID: 27613835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition.
    Koplev S; Lin K; Dohlman AB; Ma'ayan A
    PLoS Comput Biol; 2018 Jan; 14(1):e1005911. PubMed ID: 29293502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
    Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
    Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
    Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
    Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells.
    Joannes A; Grelet S; Duca L; Gilles C; Kileztky C; Dalstein V; Birembaut P; Polette M; Nawrocki-Raby B
    Mol Cancer Res; 2014 May; 12(5):775-83. PubMed ID: 24464917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Epigenetic Regulation of Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancer Cells by Quantitative Chromatin Immunoprecipitation of Histone Deacetylase 3 (HDAC3).
    Wang JQ; Wu MZ; Wu KJ
    Methods Mol Biol; 2016; 1436():23-9. PubMed ID: 27246206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.
    Stewart TA; Azimi I; Brooks AJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
    Int J Biochem Cell Biol; 2016 Jul; 76():64-74. PubMed ID: 27163529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
    Wang D; Haley JD; Thompson P
    BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.